Literature DB >> 24321485

In silico to in vivo splicing analysis using splicing code models.

Matthew R Gazzara1, Jorge Vaquero-Garcia2, Kristen W Lynch3, Yoseph Barash4.   

Abstract

With the growing appreciation of RNA splicing's role in gene regulation, development, and disease, researchers from diverse fields find themselves investigating exons of interest. Commonly, researchers are interested in knowing if an exon is alternatively spliced, if it is differentially included in specific tissues or in developmental stages, and what regulatory elements control its inclusion. An important step towards the ability to perform such analysis in silico was made with the development of computational splicing code models. Aimed as a practical how-to guide, we demonstrate how researchers can now use these code models to analyze a gene of interest, focusing on Bin1 as a case study. Bridging integrator 1 (BIN1) is a nucleocytoplasmic adaptor protein known to be functionally regulated through alternative splicing in a tissue-specific manner. Specific Bin1 isoforms have been associated with muscular diseases and cancers, making the study of its splicing regulation of wide interest. Using AVISPA, a recently released web tool based on splicing code models, we show that many Bin1 tissue-dependent isoforms are correctly predicted, along with many of its known regulators. We review the best practices and constraints of using the tool, demonstrate how AVISPA is used to generate high confidence novel regulatory hypotheses, and experimentally validate predicted regulators of Bin1 alternative splicing.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AVISPA; Alternative splicing; BIN1; Centronuclear myopathy (CNM); Myotonic dystrophy (DM); Splicing code

Mesh:

Substances:

Year:  2013        PMID: 24321485      PMCID: PMC4321995          DOI: 10.1016/j.ymeth.2013.11.006

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  39 in total

1.  The murine Bin1 gene functions early in myogenesis and defines a new region of synteny between mouse chromosome 18 and human chromosome 2.

Authors:  N C Mao; E Steingrimsson; J DuHadaway; W Wasserman; J C Ruiz; N G Copeland; N A Jenkins; G C Prendergast
Journal:  Genomics       Date:  1999-02-15       Impact factor: 5.736

Review 2.  Splicing regulation: from a parts list of regulatory elements to an integrated splicing code.

Authors:  Zefeng Wang; Christopher B Burge
Journal:  RNA       Date:  2008-03-27       Impact factor: 4.942

3.  Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.

Authors:  K Ge; J DuHadaway; W Du; M Herlyn; U Rodeck; G C Prendergast
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

4.  Exon inclusion is dependent on predictable exonic splicing enhancers.

Authors:  Xiang H-F Zhang; Thaned Kangsamaksin; Mann S P Chao; Joydeep K Banerjee; Lawrence A Chasin
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.

Authors:  R Wechsler-Reya; D Sakamuro; J Zhang; J Duhadaway; G C Prendergast
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

6.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene.

Authors:  Rotem Karni; Elisa de Stanchina; Scott W Lowe; Rahul Sinha; David Mu; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2007-02-18       Impact factor: 15.369

Review 7.  Splicing in disease: disruption of the splicing code and the decoding machinery.

Authors:  Guey-Shin Wang; Thomas A Cooper
Journal:  Nat Rev Genet       Date:  2007-08-29       Impact factor: 53.242

8.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.

Authors:  Gene Yeo; Christopher B Burge
Journal:  J Comput Biol       Date:  2004       Impact factor: 1.479

9.  Pre-mRNA secondary structures influence exon recognition.

Authors:  Michael Hiller; Zhaiyi Zhang; Rolf Backofen; Stefan Stamm
Journal:  PLoS Genet       Date:  2007-11       Impact factor: 5.917

10.  SplicePort--an interactive splice-site analysis tool.

Authors:  Rezarta Islamaj Dogan; Lise Getoor; W John Wilbur; Stephen M Mount
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

View more
  4 in total

1.  Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.

Authors:  Elena Sotillo; David M Barrett; Kathryn L Black; Asen Bagashev; Derek Oldridge; Glendon Wu; Robyn Sussman; Claudia Lanauze; Marco Ruella; Matthew R Gazzara; Nicole M Martinez; Colleen T Harrington; Elaine Y Chung; Jessica Perazzelli; Ted J Hofmann; Shannon L Maude; Pichai Raman; Alejandro Barrera; Saar Gill; Simon F Lacey; Jan J Melenhorst; David Allman; Elad Jacoby; Terry Fry; Crystal Mackall; Yoseph Barash; Kristen W Lynch; John M Maris; Stephan A Grupp; Andrei Thomas-Tikhonenko
Journal:  Cancer Discov       Date:  2015-10-29       Impact factor: 39.397

2.  A study of splicing mutations in disorders of sex development.

Authors:  Flavia Leme de Calais; Lindsay D Smith; Michela Raponi; Andréa Trevas Maciel-Guerra; Gil Guerra-Junior; Maricilda Palandi de Mello; Diana Baralle
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

3.  Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation.

Authors:  Nicole M Martinez; Laura Agosto; Jinsong Qiu; Michael J Mallory; Matthew R Gazzara; Yoseph Barash; Xiang-Dong Fu; Kristen W Lynch
Journal:  Genes Dev       Date:  2015-10-01       Impact factor: 11.361

4.  Integrative deep models for alternative splicing.

Authors:  Anupama Jha; Matthew R Gazzara; Yoseph Barash
Journal:  Bioinformatics       Date:  2017-07-15       Impact factor: 6.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.